title: Estimation of glomerular filtration rate in diabetic subjects: Cockcroft formula or modification of Diet in Renal Disease study equation?
abstract: OBJECTIVE
  The Cockcroft-Gault formula is recommended for the evaluation of renal function in diabetic patients. The more recent Modification of Diet in Renal Disease (MDRD) study equation seems more accurate, but it has not been validated in diabetic patients. This study compares the two methods.
  
  
  METHODS
  In 160 diabetic patients, we compared the Cockcroft-Gault formula and MDRD equation estimations to glomerular filtration rates (GFRs) measured by an isotopic method ((51)Cr-EDTA) by correlation studies and a Bland-Altman procedure. Their accuracy for the diagnosis of moderately (GFR <60 ml . min(-1) . 1.73 m(-2)) or severely (GFR <30 ml . min(-1) . 1.73 m(-2)) impaired renal function were compared with receiver operating characteristic (ROC) curves.
  
  
  RESULTS
  Both the Cockcroft-Gault formula (r = 0.74; P < 0.0001) and MDRD equation (r = 0.81; P < 0.0001) were well correlated with isotopic GFR. The Bland-Altman procedure revealed a bias for the MDRD equation, which was not the case for the Cockcroft-Gault formula. Analysis of ROC curves showed that the MDRD equation had a better maximal accuracy for the diagnosis of moderate (areas under the curve [AUCs] 0.868 for the Cockcroft-Gault formula and 0.927 for the MDRD equation; P = 0.012) and severe renal failure (AUC 0.883 for the Cockcroft-Gault formula and 0.962 for the MDRD equation; P = 0.0001). In the 87 patients with renal insufficiency, the MDRD equation estimation was better correlated with isotopic GFR (Cockcroft-Gault formula r = 0.57; the MDRD equation r = 0.78; P < 0.01), and it was not biased as evaluated by the Bland-Altman procedure.
  
  
  CONCLUSIONS
  Although both equations have imperfections, the MDRD equation is more accurate for the diagnosis and stratification of renal failure in diabetic patients.
authors.affiliation: Nutrition-Diabétologie, Hôpital Haut-Lévêque, Avenue de Magellan, 33600 Pessac, France. vincent.rigalleau@wanadoo.fr
authors.forename: Vincent
authors.initials: V
authors.lastname: Rigalleau
authors.forename: Catherine
authors.initials: C
authors.lastname: Lasseur
authors.forename: Caroline
authors.initials: C
authors.lastname: Perlemoine
authors.forename: Nicole
authors.initials: N
authors.lastname: Barthe
authors.forename: C
authors.initials: C
authors.lastname: Raffaitin
authors.forename: Chung
authors.initials: C
authors.lastname: Liu
authors.forename: Phillipe
authors.initials: P
authors.lastname: Chauveau
authors.forename: Laurence
authors.initials: L
authors.lastname: Baillet-Blanco
authors.forename: Marie-Christine
authors.initials: MC
authors.lastname: Beauvieux
authors.forename: C
authors.initials: C
authors.lastname: Combe
authors.forename: Henri
authors.initials: H
authors.lastname: Gin
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D003404:Creatinine / Q000097:blood; D003922:Diabetes Mellitus, Type 1 / Q000503:physiopathology*; D003924:Diabetes Mellitus, Type 2 / Q000503:physiopathology*; D003928:Diabetic Nephropathies / Q000145:classification / Q000175:diagnosis; D005260:Female; D005919:Glomerular Filtration Rate / Q000502:physiology*; D006442:Glycated Hemoglobin / Q000032:analysis; D006801:Humans; D008297:Male; D008875:Middle Aged; D012044:Regression Analysis
chemical_list: D003404:Creatinine; D006442:Glycated Hemoglobin